Objectives Depression and psychiatric disorders are frequent among HIV‐infected
individuals. The aim of this study was to determine the prevalence of depression and …

Objectives: HIV/hepatitis C virus (HCV) coinfection is associated with insulin resistance, but
the mechanism is unclear. We hypothesized that intestinal epithelial damage and the …

Background: Higher cumulative burden of depression among people with HIV (PWH) is
associated with poorer health outcomes; however, longitudinal relationships with …

HIV infection is characterized by a state of chronic activation of the immune system, which is
not completely reversed by antiretroviral treatment (ART). The aim of this study was to …

Objective To describe disparities along the depression treatment cascade, from indication
for antidepressant treatment to effective treatment, in HIV-infected individuals by gender and …

Objective: Eradication of hepatitis C virus (HCV) in HIV disease decreases liver and non-
liver-related morbidity and mortality. Elevated markers of monocyte/macrophage activation …

Objective. To identify the prevalence of depressive symptoms and its association with
sociodemographic, clinical and behavioral disorders among PLWHA. Method. This cross …

Objective We aimed to study the usefulness of serum soluble CD163 (sCD163) as a
biomarker for macrophage activation syndrome (MAS) associated with systemic lupus …

Objective. To evaluate the performance of serum and urinary sCD163 concentrations as
possible biomarker in systemic sclerosis (SSc). Methods. Urine and serum samples were …

Objective: To consider associations between the latest/nadir CD4+ cell count, and time
spent with CD4+ cell count less than 200 cells/μl (duration of immune depression), and …